1. Home
  2. JSPR vs SIFY Comparison

JSPR vs SIFY Comparison

Compare JSPR & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$0.61

Market Cap

26.3M

Sector

Health Care

ML Signal

HOLD

Logo Sify Technologies Limited

SIFY

Sify Technologies Limited

HOLD

Current Price

$13.90

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
JSPR
SIFY
Founded
2018
1995
Country
United States
India
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
1.2B
IPO Year
2019
1999

Fundamental Metrics

Financial Performance
Metric
JSPR
SIFY
Price
$0.61
$13.90
Analyst Decision
Buy
Analyst Count
11
0
Target Price
$15.50
N/A
AVG Volume (30 Days)
448.0K
20.5K
Earning Date
05-12-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
19.22
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$14.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$10.09
52 Week High
$2.69
$17.85

Technical Indicators

Market Signals
Indicator
JSPR
SIFY
Relative Strength Index (RSI) 42.07 37.75
Support Level $0.55 $13.41
Resistance Level $1.01 $15.29
Average True Range (ATR) 0.05 0.58
MACD -0.01 -0.07
Stochastic Oscillator 32.28 16.61

Price Performance

Historical Comparison
JSPR
SIFY

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

About SIFY Sify Technologies Limited

Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.

Share on Social Networks: